These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33724916)

  • 21. Evaluation of the new 2.0 version of the Roche SARS-CoV-2 Rapid Antigen Test.
    Flinck H; Aittoniemi J
    J Virol Methods; 2023 Sep; 319():114758. PubMed ID: 37263352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    J Infect Chemother; 2021 Feb; 27(2):406-409. PubMed ID: 33183963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Evaluation of the Rapid STANDARD Q COVID-19 Ag Test for the Screening of Severe Acute Respiratory Syndrome Coronavirus 2.
    Kim HW; Park M; Lee JH
    Ann Lab Med; 2022 Jan; 42(1):100-104. PubMed ID: 34374355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen.
    Eissa S; Alhadrami HA; Al-Mozaini M; Hassan AM; Zourob M
    Mikrochim Acta; 2021 May; 188(6):199. PubMed ID: 34041585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay.
    Kittel M; Findeisen P; Muth MC; Thiaucourt M; Gerhards C; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Apr; 105():632-638. PubMed ID: 33578017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
    Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
    Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance evaluation of a lateral flow assay for nasopharyngeal antigen detection for SARS-CoV-2 diagnosis.
    Peña-Rodríguez M; Viera-Segura O; García-Chagollán M; Zepeda-Nuño JS; Muñoz-Valle JF; Mora-Mora J; Espinoza-De León G; Bustillo-Armendáriz G; García-Cedillo F; Vega-Magaña N
    J Clin Lab Anal; 2021 May; 35(5):e23745. PubMed ID: 33675086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
    Loeffelholz MJ; Alland D; Butler-Wu SM; Pandey U; Perno CF; Nava A; Carroll KC; Mostafa H; Davies E; McEwan A; Rakeman JL; Fowler RC; Pawlotsky JM; Fourati S; Banik S; Banada PP; Swaminathan S; Chakravorty S; Kwiatkowski RW; Chu VC; Kop J; Gaur R; Sin MLY; Nguyen D; Singh S; Zhang N; Persing DH
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32366669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as of November 20, 2020.
    Hayer J; Kasapic D; Zemmrich C
    Int J Infect Dis; 2021 Jul; 108():592-602. PubMed ID: 34015523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan.
    Takeuchi Y; Akashi Y; Kato D; Kuwahara M; Muramatsu S; Ueda A; Notake S; Nakamura K; Ishikawa H; Suzuki H
    J Infect Chemother; 2021 Jun; 27(6):890-894. PubMed ID: 33727026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing.
    Pilarowski G; Marquez C; Rubio L; Peng J; Martinez J; Black D; Chamie G; Jones D; Jacobo J; Tulier-Laiwa V; Rojas S; Rojas S; Cox C; Nakamura R; Petersen M; DeRisi J; Havlir DV
    Clin Infect Dis; 2021 Nov; 73(9):e3098-e3101. PubMed ID: 33367619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients.
    Hirotsu Y; Maejima M; Shibusawa M; Nagakubo Y; Hosaka K; Amemiya K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Yagi S; Kojima S; Omata M
    Int J Infect Dis; 2020 Oct; 99():397-402. PubMed ID: 32800855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.
    Linares M; Pérez-Tanoira R; Carrero A; Romanyk J; Pérez-García F; Gómez-Herruz P; Arroyo T; Cuadros J
    J Clin Virol; 2020 Dec; 133():104659. PubMed ID: 33160179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020.
    Prince-Guerra JL; Almendares O; Nolen LD; Gunn JKL; Dale AP; Buono SA; Deutsch-Feldman M; Suppiah S; Hao L; Zeng Y; Stevens VA; Knipe K; Pompey J; Atherstone C; Bui DP; Powell T; Tamin A; Harcourt JL; Shewmaker PL; Medrzycki M; Wong P; Jain S; Tejada-Strop A; Rogers S; Emery B; Wang H; Petway M; Bohannon C; Folster JM; MacNeil A; Salerno R; Kuhnert-Tallman W; Tate JE; Thornburg NJ; Kirking HL; Sheiban K; Kudrna J; Cullen T; Komatsu KK; Villanueva JM; Rose DA; Neatherlin JC; Anderson M; Rota PA; Honein MA; Bower WA
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(3):100-105. PubMed ID: 33476316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data.
    Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E
    PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an automatic integrated gene detection system for novel severe acute respiratory syndrome-related coronavirus (SARS-CoV2).
    Li Y; Li J; Zhang Y; Dai L; Li L; Liu J; Zhang S; Wu X; Hu Y; Qin C; Jiang T; Kang X
    Emerg Microbes Infect; 2020 Dec; 9(1):1489-1496. PubMed ID: 32543298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
    Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
    Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients.
    Buchan BW; Hoff JS; Gmehlin CG; Perez A; Faron ML; Munoz-Price LS; Ledeboer NA
    Am J Clin Pathol; 2020 Sep; 154(4):479-485. PubMed ID: 32687186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.